TABLE 3.
Groupa | Clone type(s) | No. (%) of patients positive for strain(s) of A. actinomycetemcomitans at 12 mo |
---|---|---|
JP2 strain infected | JP2 | 14 (56)b,c |
Non-JP2 | 0 (0) | |
Both JP2 and non-JP2 | 0 (0) | |
Not detectable | 11 (44) | |
Non-JP2 strain | JP2 | 0 (0) |
infected | Non-JP2 | 18 (72)b,c |
Both JP2 and non-JP2 | 0 (0) | |
Not detectable | 7 (28) |
At 0 months, both groups had 25 patients (100%) positive for A. actinomycetemcomitans.
Intragroup reduction from 0 months to 12 months is significant as analyzed by the Wilcoxon test (JP2-strain-infected group, P = 0.003; non-JP2-strain-infected group, P = 0.0180).
Prevalence of non-JP2 strains at 12 months is not significantly different from that of JP2 strains at 12 months by the Mann-Whitney test (P = 0.3320).